Primary Site >> Liver Cancer
Gene >> MAD2L1
|
|
|
|
|
|---|---|---|---|---|
|
Ref: Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. PMID: 11400114 Ref: Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. PMID: 11572763 |
Ref: Modulations of cell cycle checkpoints during HCV associated disease. PMID: 19664251 |
Ref: Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. PMID: 25753876 |
Ref: Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. PMID: 28238542 Ref: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma. PMID: 28318489 Ref: MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1. PMID: 28609841 |
Ref: Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction. PMID: 29728556 Ref: DNA methylation biomarkers for hepatocellular carcinoma. PMID: 30245591 Ref: Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. PMID: 30341252 Ref: Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients. PMID: 30363964 |